Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGFR3 inhib
>>
Knight Therap
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
59
118
177
236
295
354
413
472
531
590
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Pemazyre
(pemigatinib) / Incyte
